Nevirapine Articles
23 members of BI's HIV donation program
18 March 2002
BI's tipranavir effective in resistant HIV
11 March 2002
Viramune is safe, says S African MRC
4 March 2002
S Africa stands firm on Viramune in HIV/AIDS
4 March 2002
South Africa HIV/AIDS spending to boost Viramune use in MTCT
25 February 2002
Mandela slams Sth Africa govt on AIDS
25 February 2002
S African HIV/AIDS MTCT policy easing?
18 February 2002
S African doctors slam govt over nevirapine
11 February 2002
S African states accept free Viramune from BI
4 February 2002
S African state using nevirapine for MTCT
28 January 2002
S African govt to fight nevirapine ruling
7 January 2002
S African govt to fight nevirapine ruling
21 December 2001
Boehringer Ingelheim Viramune program
3 December 2001
HIV/AIDS patients "must get drug treatment," says Mandela
3 December 2001
S African drug supply row will go to court
20 November 2001
BI reports 96-week Viramune data
30 October 2001
Need for differentiated drug access policies
30 October 2001
TAC seeks to settle with S Africa govt
30 October 2001
South African govt to fight TAC on AIDS drug
17 September 2001
12 countries join BI's Viramune Donation Program
13 September 2001
Boeh Ingelheim hires Axios to expand Viramune access
7 September 2001
TAC sues S African govt over Viramune
22 August 2001
Cipla drops HIV/AIDS cocktail price in India
13 July 2001
DuPont's Sustiva tops PI therapy over 3 years
10 July 2001
BI's tipranavir effective as HIV salvage regimen
10 July 2001
UK MRC to fund Viramune study
3 July 2001
Tanzania: free Viramune for pregnant women
2 July 2001
Cipla to supply Nigeria with HIV/AIDS drugs
9 May 2001
IFPMA urges govts to act on drug distribution
6 April 2001
Drug majors cut AIDS drug prices further
7 March 2001
Cipla talks with WHO over AIDS drug offer
1 March 2001
10 countries to get Cipla's AIDS drugs
26 February 2001
Kenyan moves to buy cheap AIDS drugs
26 February 2001
Correction
19 February 2001
Cipla talks with MNCs over HIV drug offer
13 February 2001
S Africa nevirapine trial in HIV mothers
31 January 2001
Warnings issued on use of B-MS' antiretrovirals in pregnancy
8 January 2001
Boehringer Ingelheim starts free supplies of Viramune
30 November 2000
Cipla offers free anti-HIV drug for India
24 November 2000
Antiretrovirals backed by WHO for HIV MTCT
10 November 2000
South African AIDS guide drugs row
26 October 2000
First-half sales rise 19% at Boeh Ingelheim
25 August 2000
Still no nevirapine for SA's HIV-mothers
15 August 2000
HIV/AIDS therapy sales forecasts to 2009
3 August 2000
German govt and Boeh Ingelheim in AIDS partnership
21 July 2000
BI offers free Viramune to developing countries
7 July 2000
Cipla permitted to market nevirapine in India
13 April 2000
BI's Viramune shows efficacy in advanced HIV
3 February 2000
Abbott's ABT-378/r, efficacy in PI-resistant patients
3 February 2000
New generation of anti-HIV drugs unveiled at ICAAC
13 October 1999
Viramune cuts vertical HIV transmission
21 July 1999
GW gains EU approval for Ziagen
13 July 1999
New trials support role of nevirapine in HIV
29 March 1999
Roxane's Viramune Okayed For Pediatrics
26 November 1998
First Approval Of DuPont's Sustiva In USA
21 September 1998
Euro HIV/AIDS Market Competition
2 September 1998
Agouron Shopping For HIV Portfolio
1 July 1998
Viramune Launched In The UK For HIV
15 April 1998
Anti-Infective News In Brief
19 March 1998
EMEA CPMP Plenary Meeting In February
10 March 1998
Pramipexole Approved In The European Union
5 March 1998
A Real Challenge To HIV With New Therapies?
12 February 1998
Global Anti-HIV Market To Top $5 Billion In 2005
21 January 1998
Can Protease Inhibitor Resistance Be Combatted?
4 November 1997
Roche's Invirase Confers Survival Benefit
20 October 1997
NDA Filed For New Soft-Gel Saquinavir
9 October 1997
First Launch Of P&U's Delavirdine In USA
26 June 1997
HIV Drug-Resistant Strain Reported
9 June 1997
First Approval For Delavirdine NNRTI
7 April 1997
BI's Viramune Safe In Pregnancy
3 February 1997
Record Number Of New Chemical Entities In 1996
20 January 1997
Product News In 1996 Dominated By CNS
23 December 1996
Split Verdict From Panel On P&U's Delavirdine
2 December 1996
First Launch Of Boehringer Ingelheim's Nevirapine
2 September 1996
Delavirdine Filed In USA; NNRTI Role Reviewed
29 July 1996
Lamivudine Study Halted Early On Ethical Grounds
29 July 1996
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
